Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04042337 · ClinicalTrials.gov registry record · NA

Improving Access to Pivotal Response Treatment (PRT) Via Telehealth Parent Training

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
101
Enrollment target

NCT04042337: Completed NA study, sponsored by Stanford University.

NCT04042337 is a NA study that has completed, run by Stanford University. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04042337, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
101 participants
Enrollment target

Study Summary

There is an urgent need for improved access to effective autism treatments. With advances in technology, distance learning models have particular promise for families who cannot access evidence-based parent training locally or may be on long wait-lists for behavioral treatments. Pivotal Response Treatment (PRT) is an established treatment for autism spectrum disorder (ASD); however, a telehealth PRT model has not yet been evaluated in a controlled trial. This study will examine the effects of training parents in PRT via secure video conferencing and investigate 1) whether parents can learn via telehealth to deliver PRT in the home setting (PRT-T) and 2) whether their children will show greater improvement in functional communication skills compared to children in a waitlist control group. Participants will include 40 children age 2 to 5 years with ASD and significant language delay. Eligible children will be randomly assigned to either PRT-T (N=20) or waiting list (N=20). Weekly 60-minute parent training sessions will be delivered for 12 weeks via secure video conferencing software by a PRT-trained study therapist. The effects of PRT-T on parent fidelity of PRT implementation, child communication deficits including frequency of functional verbal utterances, and parent-report of communication skills on standardized questionnaires will be evaluated. This research will provide a foundation for wider dissemination of technology-based solutions to improve access to ASD treatment.

Interventions

  • BEHAVIORAL Pivotal Response Treatment

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2020-04-13
Est. Completion 2025-10-29
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT04042337

The ClinicalTrials.gov registry entry for NCT04042337 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Pivotal Response Treatment is the first listed.

NCT04042337 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04042337 about?

NCT04042337 is a clinical study titled "Improving Access to Pivotal Response Treatment (PRT) Via Telehealth Parent Training". There is an urgent need for improved access to effective autism treatments. With advances in technology, distance learning models have particular promise for families who cannot access evidence-based parent training locally or may be on long wait-lists for behavioral treatments. Pivotal Response Tre...

What is the current status of trial NCT04042337?

This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2020-04-13. Estimated completion is 2025-10-29.

What interventions are being tested in trial NCT04042337?

The interventions under investigation include: Pivotal Response Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT04042337?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.